Advertisements


Alexion to present results from ALXN1210 Phase 3 study at EHA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2018

Calithera to present results from Phase 1 CB-839 combination study at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Karyopharm to present Phase 2 SEAL study results at ASCO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Glaxo, J&J"s Dual Drug HIV Regimen Succeeds in Phase III Study

Glaxo (GSK) and Johnson and Johnson report positive top line results from a late-stage study of their injectable two-drug regimen for the treatment of HIV. GlaxoSmithKline’s GSK HIV drug subsidiary-ViiV H.....»»

Category: smallbizSource: nyt3 hr. 18 min. ago

Strongbridge Biopharma: "positive" results from Phase 3 SONICS study of RECORLEV

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 8th, 2018

Protagonist announces results from re-analysis fo Phase 2 Propel study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 6th, 2018

Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update

- Phase 1a/1b study of AB-506, a second-generation oral capsid inhibitor, initiated - Phase 1a/1b study of AB-452, a novel and proprietary oral RNA destabilizer, expec.....»»

Category: earningsSource: benzingaAug 2nd, 2018

Denali up 10.7% after reporting "positive" Phase 1 DNL201 study results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Denali announces "positive" clinical results from Phase 1 DNL201 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

RedHill Biopharma clarifies top-line results from Phase III study of RHB-104

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

Redhill Achieves Positive Results For Phase 2b Study, FDA Meeting On Deck

Redhill Achieves Positive Results For Phase 2b Study, FDA Meeting On Deck.....»»

Category: topSource: seekingalphaJul 31st, 2018

RedHill Earns Long-Awaited Boost On Positive Crohn"s Data

REDHILL BIOPHAR/S ADR (NASDAQ: RDHL) achieved positive top-line results in its Phase 3 study of RHB-104 in Crohn’s disease, according to a Monday press release. read more.....»»

Category: blogSource: benzingaJul 30th, 2018

Biogen announces results from Phase 2 BAN2401 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Biogen announces detailed results from Phase 2 study of elenbecestat

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 25th, 2018

Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow

Allergan (AGN) Abicipar SEQUOIA & CEDAR Phase 3 Study Results - Slideshow.....»»

Category: topSource: seekingalphaJul 19th, 2018

Viking Therapeutics announces VK5211 Phase 2 study results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 17th, 2018

NEJM publishes results from phase 2 study of vaccines reducing TB infections

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2018

Scynexis announces results from Phase 2b study evaluating oral SCY-078

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

Celsion announces publication of ThermoDox Phase I clinical study results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

PTC Therapeutics announces "positive" results from Translarna Phase II Study 030

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 9th, 2018

After Biogen"s Alzheimer"s Update, Wall Street Reacts

Biogen Inc (NASDAQ: BIIB) and its Japanese partner Eisai disclosed encouraging results from an 18-month Phase 2 study of its Alzheimer's therapy BAN2401. .....»»

Category: blogSource: benzingaJul 6th, 2018